STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D] Steakholder Foods Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D
Rhea-AI Filing Summary

Steakholder Foods (STKH): Gefen Capital entities, D.B.W. Holdings (2005) Ltd., and David Wiessman filed a Schedule 13D reporting significant stakes in the company’s American Depositary Shares (ADSs). Gefen LP, its GP and management company report shared power over 297,081 ADSs, representing 19.8% of the outstanding ADSs. D.B.W. Holdings and David Wiessman report shared power over 313,105 ADSs, representing 20.9%.

The filing details recent transactions: Gefen LP purchased ADSs in a private placement at $7.00 per ADS (total $870,000); D.B.W. provided a $870,000 convertible loan at 8% per annum, maturing on May 30, 2027, converted into 16,023 ADSs on Nov 3, 2025. In the Twine acquisition, consideration included 158,465 ADSs and 145,355 pre-funded milestone warrants (up to 10 years, with a 24.99% beneficial ownership limitation). Gefen LP received 136,191 ADSs, and directors Limor Ganot and Snir Wiessman were appointed, each granted RSUs vesting into 7,956 ADSs.

Positive
  • None.
Negative
  • None.

Insights

Large holders disclose ~20% stakes with board seats and warrants.

Gefen LP reports shared power over 297,081 ADSs (19.8%), while D.B.W./David Wiessman report 313,105 ADSs (20.9%). Recent financings include a $870,000 private placement at $7.00 per ADS and a $870,000 convertible loan at 8% converted into 16,023 ADSs on Nov 3, 2025.

The Twine deal added 158,465 ADSs and 145,355 pre-funded milestone warrants, with a 24.99% Beneficial Ownership Limitation and up to 10-year term. Such structures can cap near-term exercises and stagger potential share issuances.

Two directors (Limor Ganot, Snir Wiessman) joined the board, each granted RSUs vesting into 7,956 ADSs. Actual market impact depends on warrant exercise conditions and any future resale registrations permitted by agreements.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The percentage of Shares reported to be beneficially owned by the Reporting Persons is based on information from the Issuer.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentage of Shares reported to be beneficially owned by the Reporting Persons is based on information from the Issuer.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentage of Shares reported to be beneficially owned by the Reporting Persons is based on information from the Issuer.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentage of Shares reported to be beneficially owned by the Reporting Persons is based on information from the Issuer.


SCHEDULE 13D




Comment for Type of Reporting Person:
The percentage of Shares reported to be beneficially owned by the Reporting Persons is based on information from the Issuer.


SCHEDULE 13D


Gefen Capital Investments, LP
Signature:/s/ Limor Ganot
Name/Title:Limor Ganot/Partner
Date:11/10/2025
Gefen Capital Investments GP, LP
Signature:/s/ Limor Ganot
Name/Title:Limor Ganot/Partner
Date:11/10/2025
US Israel Gefen Capital Management Ltd.
Signature:/s/ Snir Wiessman
Name/Title:Snir Wiessman, Director
Date:11/10/2025
D.B.W. Holdings (2005) Ltd.
Signature:/s/ David Wiessman
Name/Title:David Wiessman, Director
Date:11/10/2025
David Wiessman
Signature:/s/ David Wiessman
Name/Title:David Wiessman
Date:11/10/2025

FAQ

What stakes were disclosed in Steakholder Foods (STKH) on this Schedule 13D?

Gefen LP and affiliates reported 297,081 ADSs (19.8%), and D.B.W. Holdings/David Wiessman reported 313,105 ADSs (20.9%).

What warrants were included in the Twine transaction for STKH?

Consideration included 145,355 pre-funded milestone warrants to purchase ADSs, exercisable upon milestones, with a 24.99% beneficial ownership cap for up to 10 years.

What recent financings involving STKH are described?

Gefen LP bought ADSs at $7.00 per ADS for $870,000, and D.B.W. provided a $870,000 loan at 8%, maturing May 30, 2027, later converted into 16,023 ADSs.

How many ADSs did Gefen LP receive in the Twine acquisition?

Gefen LP received 136,191 ADSs as part of the Twine securities purchase agreement.

Were there board changes at Steakholder Foods (STKH)?

Yes. Limor Ganot and Snir Wiessman were appointed as directors, each receiving RSUs vesting into 7,956 ADSs.

What is the ADS-to-ordinary share ratio for STKH?

Each ADS represents 4,000 ordinary shares.

Is there any voting agreement related to director elections?

Gefen LP signed an undertaking to refrain from voting against director nominees of Yaron Kaiser and Arik Kaufman.
STEAKHOLDER FOODS LTD

NASDAQ:STKH

STKH Rankings

STKH Latest News

STKH Latest SEC Filings

STKH Stock Data

2.32M
595.15k
1.01%
Packaged Foods
Consumer Defensive
Link
Israel
Rehovot